Chronic kidney disease is a significant cause of illness and death in dogs and is often caused by glomerular diseases. A specific category of glomerular disease called immune complex-mediated glomerulonephritis (ICGN) accounts for approximately 50% of dogs that have a kidney biopsy due to suspicion of glomerular disease.
Currently, ICGN can only be diagnosed with evaluation of a kidney biopsy, as there are no available biomarkers that can accurately identify this category of glomerular disease. Ongoing research is exploring potential biomarkers that could allow veterinarians to non-invasively diagnose ICGN. This would allow for more confidence in the appropriate treatment of dogs with this type of kidney disease, particularly in patients that are not good candidates for a kidney biopsy.
In this webinar, we will review the various diagnostic categories of glomerular disease in dogs and learn about potential new tools for differentiating immune complex-mediated glomerulonephritis from other forms of kidney disease.
Original Air Date: Tuesday, March 25, 2025
Speaker: Mary Nabity, DVM, PhD
This program has been RACE approved for 1 hour of continuing education credit in jurisdictions that recognize RACE approval.
Learn more about Dr. Nabity’s CHF-funded research:
03281-MOU: Kidney Disease in Shetland Sheepdogs
03106: Clinical Validation of Urinary miR-126 as a Marker of Immune Complex- Mediated Glomerulonephritis in Dogs
02066: Identification of Novel Biomarkers and Therapeutic Targets for Chronic Kidney Disease in Dogs
02152: Translation of MicroRNA into an Early Diagnostic Test for Chronic Kidney Disease
